Since tofersen was shown to be an effective treatment for SOD1-ALS [21, 22], genetic testing for pathogenic SOD1 variants should be recommended early to all ALS patients, regardless of their family history. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.